Not applicableStudy completedNCT01387581What this trial is testingDoes the Aid of MelaFind Affect Clinical Management DecisionsWho this might be right forMelanoma MELA Sciences, Inc. 227
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Not applicableActive Not RecruitingNCT06598137What this trial is testingStudy to Examine Lesions of the Skin Using Confocal Laser MicroscopyWho this might be right forBenign Skin TumorBasal Cell CarcinomaMelanoma+1 more LMU Klinikum 645
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836What this trial is testingSafety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)Who this might be right forMelanoma Merck Sharp & Dohme LLC 976
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Looking for participantsNCT05588453What this trial is testingNatural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more Kari Kendra 24
Not applicableLooking for participantsNCT05253872What this trial is testingThe MELAcare Study: A New Method for Surveillance of Melanoma PatientsWho this might be right forCutaneous Melanoma Herlev and Gentofte Hospital 378
Early research (Phase 1)UnknownNCT04072900What this trial is testingA Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in MelanomaWho this might be right forMelanoma (Skin) Xiangya Hospital of Central South University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT04401995What this trial is testingStudy of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. NivolumabWho this might be right forMelanoma Diwakar Davar 9
Large-scale testing (Phase 3)Study completedNCT01866319What this trial is testingStudy to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)Who this might be right forMelanoma Merck Sharp & Dohme LLC 834
Testing effectiveness (Phase 2)Ended earlyNCT00849875What this trial is testingSafety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsWho this might be right forMelanoma GlaxoSmithKline 48
Testing effectiveness (Phase 2)Study completedNCT00074230What this trial is testingVaccine Therapy in Treating Patients With Stage IV Cutaneous MelanomaWho this might be right forMelanoma (Skin) University Hospital Erlangen 82
Testing effectiveness (Phase 2)Ended earlyNCT00722098What this trial is testingComparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma PatientsWho this might be right forMalignant Melanoma Stage IV Baylor Research Institute 9
Not applicableEnded earlyNCT02355587What this trial is testingFive Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient OutcomesWho this might be right forCutaneous Melanoma Castle Biosciences Incorporated 72
Not applicableStudy completedNCT02057393What this trial is testingInfrared Lymphangiography as a Method of Sentinel Node IdentificationWho this might be right forMelanomaSentinel Node Milton S. Hershey Medical Center 89
Testing effectiveness (Phase 2)Looking for participantsNCT07237100What this trial is testingMirdametinib in Patients With Advanced NF1-mutant MelanomaWho this might be right forAdvanced Unresectable MelanomaMetastatic Melanoma Kevin Kim, MD 10
Not applicableStudy completedNCT02058953What this trial is testingCNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain MetastasesWho this might be right forMelanomaBrain Metastases University of Pittsburgh 7
Testing effectiveness (Phase 2)UnknownNCT04521075What this trial is testingA Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLCWho this might be right forMelanoma Stage IVUnresectable MelanomaNSCLC Stage IV Ella Therapeutics Ltd 42